kresmion.
Pull a receipt
PREVIEW · SAMPLE DATA
This is the NTLA dossier with made-up numbers. Sign up free to see live prices, insider trades, 13F flows and fundamentals for NTLA.

NTLA

Intellia Therapeutics, Inc.
Biotechnology · Biotechnology
$102.86 sample
+0.30 (+0.29%) 1D
☆ Watch
Market cap
$346.1B
Price as of
2026-10-29
Latest filing
8-K · 2026-10-20
Alerts
8
Price$102.86 +7.02% 3M daily closessample
102.8694.17
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first
  • Oct 26INSInsider buy: General Counsel
  • Oct 20SEC8-K filed: material event
  • Oct 14INSInsider sell: Chief Financial Officer
  • Oct 06SEC10-Q filed
  • Sep 28INSInsider sell: EVP, Operations
  • Sep 17SEC8-K filed: material event
  • Sep 08SECForm 144 filed
  • Aug 28SECForm 144 filed
Sign up to see the real NTLA record →

Company facts

SEC EDGAR registration
Name
Intellia Therapeutics, Inc.
Sector
Biotechnology
Industry
Biotechnology
Smart-money score
-12sample, -100 to +100
Reporting currency
USD

Who is positioning in NTLA

sample
Insiders
9 insider transactions over 90 days, net selling, $529.9M
Congress
1 members traded over 90 days
Institutions · 13F
22 funds hold $3.3B
Activists · 13D/G
No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end
Revenue$12.3B +9.7% y/y
Q4 2024Q3 2026
Inventory$7.6B +14.2% y/y
Q4 2024Q3 2026
Accounts receivable$5.5B +15.0% y/y
Q4 2024Q3 2026
Total debt$14.9B +15.9% y/y
Q4 2024Q3 2026

Peers

sample
Sample peer A
$262.0B +10.5% 3M
Sample peer B
$185.3B -0.8% 3M
Sample peer C
$158.4B +3.8% 3M
Sample peer D
$183.0B -4.9% 3M
Sample peer E
$188.7B +9.6% 3M
Preview. Company name, sector and industry are from SEC EDGAR; every price, flow, filing count and fundamental on this page is sample data generated for the preview and is not NTLA's real figure. Nothing here is investment advice.